Organogenesis Holdings, Inc. (NASDAQ:ORGO) Q4 2018 Earnings Conference Call March 18, 2019 5:00 PM ET Company Participants Gary Gillheeney – Chief Executive Officer Tim Cunningham – Chief Financial Officer Conference Call Participants Ryan Zimmerman – BTIG Kristen Stewart – Barclays Operator Good afternoon, ladies and gentlemen, and welcome to the Fourth Quarter and Fiscal Year 2018 Earnings Conference Call for Organogenesis Holdings, Incorporated. At this time, all participants have been placed in a listen ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-37906 ORGANOGENESIS HOLDINGS INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 98-1329150 (State or Other Jurisdiction of (I.R.S. E ...